Jeffrey C. Pearson, PharmD (he/him/his)

Advanced Practice Pharmacy Specialist, Infectious Diseases
Brigham and Women's Hospital
Boston, MA, United States

Jeffrey Pearson, PharmD, BCIDP is an advanced practice pharmacy specialist in infectious diseases at Brigham and Women’s Hospital in Boston, where he serves as the point person for the hospital’s antimicrobial stewardship program and COVID-19 therapeutic guidelines. Dr. Pearson received his Doctor of Pharmacy from Northeastern University in 2014. He completed his PGY-1 residency at Mount Auburn Hospital and PGY-2 residency in infectious diseases at Beth Israel Deaconess Medical Center. He serves leadership roles on committees for the Society of Infectious Diseases Pharmacists (SIDP) and Massachusetts Society of Health-System Pharmacists (MSHP). His clinical interests include antimicrobial stewardship, antimicrobial PK-PD, and nontuberculous mycobacterial infections.

Disclosure(s): inflarx: Advisor/Consultant

Presentation(s):

• 94 - A Day With the Stewardship Pager

  Thursday, October 17, 2024
  3:15 PM – 4:30 PM US PT

• 311 - Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:42 AM – 10:54 AM US PT

• 312 - Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:54 AM – 11:06 AM US PT